共 50 条
- [41] Phase I trial of SNS-595 in patients with advanced malignancies.JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 159S - 159SAdvani, R论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Stanford, CA 94305 USAGordon, M论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Stanford, CA 94305 USAHurwitz, H论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Stanford, CA 94305 USAMendelson, D论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Stanford, CA 94305 USAWakelee, H论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Stanford, CA 94305 USAEbbinghaus, S论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Stanford, CA 94305 USAHoch, U论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Stanford, CA 94305 USASilverman, J论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Stanford, CA 94305 USAHavrilla, N论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Stanford, CA 94305 USAAdelman, D论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Stanford, CA 94305 USA
- [42] Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignanciesJOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)Reilley, Matthew论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USABailey, Ann Marie论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USASubbiah, Vivek论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USAJanku, Filip论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USANaing, Aung论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USAFalchook, Gerald Steven论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USAKarp, Daniel D.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USAPiha-Paul, Sarina Anne论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USATsimberidou, Apostolia Maria论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USAFu, Siqing论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USAZinner, Ralph论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USALim, JoAnn论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USABean, Stacie A.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USABass, Allison论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USAMontez, Sandra论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USAVence, Luis M.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USASharma, Padmanee论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USAAllison, James Patrick论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USAMeric-Bernstam, Funda论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USAHong, David S.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX USA
- [43] Phase I trial of paclitaxel, bevacizumab, and temsirolimus in advanced solid malignancies.JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)Westin, Shannon Neville论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAStashi, Erin论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAPal, Navdeep论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAUrbauer, Diana L.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAJanku, Filip论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAPiha-Paul, Sarina Anne论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USANaing, Aung论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USATsimberidou, Apostolia Maria论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAFu, Siqing论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAHong, David S.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USASubbiah, Vivek论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAKarp, Daniel D.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAColeman, Robert L.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAMeric-Bernstam, Funda论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAKurzrock, Razelle论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
- [44] Phase I trial of pemetrexed (P) plus docetaxel (D) in advanced malignanciesJOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)Petrylak, D. P.论文数: 0 引用数: 0 h-index: 0机构: Columbia Presbyterian Med Ctr, New York, NY 10032 USAHood, K.论文数: 0 引用数: 0 h-index: 0机构: Columbia Presbyterian Med Ctr, New York, NY 10032 USAXu, R.论文数: 0 引用数: 0 h-index: 0机构: Columbia Presbyterian Med Ctr, New York, NY 10032 USAGill, J. F.论文数: 0 引用数: 0 h-index: 0机构: Columbia Presbyterian Med Ctr, New York, NY 10032 USANicol, S. J.论文数: 0 引用数: 0 h-index: 0机构: Columbia Presbyterian Med Ctr, New York, NY 10032 USA
- [45] Phase I trial of SU14813 in patients with advanced solid malignanciesANNALS OF ONCOLOGY, 2011, 22 (01) : 195 - 201Fiedler, W.论文数: 0 引用数: 0 h-index: 0机构: Univ Med Ctr Hamburg Eppendorf, Dept Oncol, BMT Sect Pneumol, Hubertus Wald Tumorzentrum,Univ Canc Ctr Hamburg, D-20246 Hamburg, Germany Univ Med Ctr Hamburg Eppendorf, Dept Oncol, BMT Sect Pneumol, Hubertus Wald Tumorzentrum,Univ Canc Ctr Hamburg, D-20246 Hamburg, Germany论文数: 引用数: h-index:机构:Lasch, P.论文数: 0 引用数: 0 h-index: 0机构: Univ Med Ctr Hamburg Eppendorf, Dept Oncol, BMT Sect Pneumol, Hubertus Wald Tumorzentrum,Univ Canc Ctr Hamburg, D-20246 Hamburg, Germany Univ Med Ctr Hamburg Eppendorf, Dept Oncol, BMT Sect Pneumol, Hubertus Wald Tumorzentrum,Univ Canc Ctr Hamburg, D-20246 Hamburg, Germanyvan der Horst, I.论文数: 0 引用数: 0 h-index: 0机构: Vrije Univ Amsterdam Med Ctr, Dept Med Oncol, Amsterdam, Netherlands Univ Med Ctr Hamburg Eppendorf, Dept Oncol, BMT Sect Pneumol, Hubertus Wald Tumorzentrum,Univ Canc Ctr Hamburg, D-20246 Hamburg, GermanyBrega, N.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Italia Srl, Clin Oncol, Milan, Italy Univ Med Ctr Hamburg Eppendorf, Dept Oncol, BMT Sect Pneumol, Hubertus Wald Tumorzentrum,Univ Canc Ctr Hamburg, D-20246 Hamburg, GermanyCourtney, R.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Oncol, Clin Pharmacol, San Diego, CA USA Univ Med Ctr Hamburg Eppendorf, Dept Oncol, BMT Sect Pneumol, Hubertus Wald Tumorzentrum,Univ Canc Ctr Hamburg, D-20246 Hamburg, GermanyAbbattista, A.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Italia Srl, Exploratory Dev Asset Team, Milan, Italy Univ Med Ctr Hamburg Eppendorf, Dept Oncol, BMT Sect Pneumol, Hubertus Wald Tumorzentrum,Univ Canc Ctr Hamburg, D-20246 Hamburg, GermanyShalinsky, D. R.论文数: 0 引用数: 0 h-index: 0机构: Pfizer Oncol, Translat Oncol, San Diego, CA USA Univ Med Ctr Hamburg Eppendorf, Dept Oncol, BMT Sect Pneumol, Hubertus Wald Tumorzentrum,Univ Canc Ctr Hamburg, D-20246 Hamburg, GermanyBokemeyer, C.论文数: 0 引用数: 0 h-index: 0机构: Univ Med Ctr Hamburg Eppendorf, Dept Oncol, BMT Sect Pneumol, Hubertus Wald Tumorzentrum,Univ Canc Ctr Hamburg, D-20246 Hamburg, Germany Univ Med Ctr Hamburg Eppendorf, Dept Oncol, BMT Sect Pneumol, Hubertus Wald Tumorzentrum,Univ Canc Ctr Hamburg, D-20246 Hamburg, GermanyBoven, E.论文数: 0 引用数: 0 h-index: 0机构: Vrije Univ Amsterdam Med Ctr, Dept Med Oncol, Amsterdam, Netherlands Univ Med Ctr Hamburg Eppendorf, Dept Oncol, BMT Sect Pneumol, Hubertus Wald Tumorzentrum,Univ Canc Ctr Hamburg, D-20246 Hamburg, Germany
- [46] Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignanciesJOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5Reilley, Matthew J.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Canc Med, 1515 Holcombe Blvd, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USABailey, Ann论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Inst Personalized Canc Therapy, 1515 Holcombe Blvd, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USASubbiah, Vivek论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USAJanku, Filip论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USANaing, Aung论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USAFalchook, Gerald论文数: 0 引用数: 0 h-index: 0机构: HealthOne, Sarah Cannon Res Inst, 1800 Williams St,Suite 300, Denver, CO 80218 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USAKarp, Daniel论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USAPiha-Paul, Sarina论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USATsimberidou, Apostolia论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USAFu, Siqing论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USALim, Joann论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Pharamacy Clin Programs, 1515 Holcombe Blvd, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USABean, Stacie论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Pharamacy Clin Programs, 1515 Holcombe Blvd, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USABass, Allison论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Pharamacy Clin Programs, 1515 Holcombe Blvd, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USAMontez, Sandra论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USAVence, Luis论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Immunol, 1515 Holcombe Blvd, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USASharma, Padmanee论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Immunol, 1515 Holcombe Blvd, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USAAllison, James论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Immunol, 1515 Holcombe Blvd, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USAMeric-Bernstam, Funda论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USAHong, David S.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, John Mendelsohn Fac Ctr FC83050, Dept Canc Med, 1515 Holcombe Blvd,Unit 0455, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USA
- [47] Phase I study of the mTOR inhibitor sirolimus and the HDAC inhibitor vorinostat in patients with advanced malignancies.JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)Park, Haeseong论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAGarrido-Laguna, Ignacio论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USANaing, Aung论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAFu, Siqing论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAFalchook, Gerald Steven论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAPiha-Paul, Sarina Anne论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAWheler, Jennifer J.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAHong, David S.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USASubbiah, Vivek论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USATsimberidou, Apostolia Maria论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAKaseb, Ahmed Omar论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAOki, Yasuhiro论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAZinner, Ralph论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAPatel, Shreyaskumar论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USABravo, Vivianne Marie Velez论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAFanale, Michelle A.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAMeric-Bernstam, Funda论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAKurzrock, Razelle论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAJanku, Filip论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
- [48] Phase Ib trial of pembrolizumab and XL888 in patients with advanced gastrointestinal malignancies.JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)Akce, Mehmet论文数: 0 引用数: 0 h-index: 0机构: Winship Canc Inst, Atlanta, GA USAAlese, Olatunji B.论文数: 0 引用数: 0 h-index: 0机构: Winship Canc Inst, Atlanta, GA USAShaib, Walid Labib论文数: 0 引用数: 0 h-index: 0机构: Winship Canc Inst, Atlanta, GA USAWu, Christina Sing-Ying论文数: 0 引用数: 0 h-index: 0机构: Winship Canc Inst, Atlanta, GA USALesinski, Gregory B.论文数: 0 引用数: 0 h-index: 0机构: Winship Canc Inst, Atlanta, GA USAEl-Rayes, Bassel F.论文数: 0 引用数: 0 h-index: 0机构: Winship Canc Inst, Atlanta, GA USA
- [49] MAT2A inhibitor AG-270/S095033 in patients with advanced malignancies: a phase I trialNATURE COMMUNICATIONS, 2025, 16 (01)Gounder, Mrinal论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY USA Weill Cornell Med Coll, New York, NY USA Mem Sloan Kettering Canc Ctr, New York, NY USAJohnson, Melissa论文数: 0 引用数: 0 h-index: 0机构: Sarah Cannon Res Inst, Nashville, TN USA Mem Sloan Kettering Canc Ctr, New York, NY USAHeist, Rebecca S.论文数: 0 引用数: 0 h-index: 0机构: Massachusetts Gen Hosp, Boston, MA USA Mem Sloan Kettering Canc Ctr, New York, NY USAShapiro, Geoffrey I.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Ctr, Boston, MA USA Mem Sloan Kettering Canc Ctr, New York, NY USAPostel-Vinay, Sophie论文数: 0 引用数: 0 h-index: 0机构: Inst Gustave Roussy, Villejuif, France INSERM, U981, Villejuif, France UCL, London, England Mem Sloan Kettering Canc Ctr, New York, NY USAWilson, Frederick H.论文数: 0 引用数: 0 h-index: 0机构: Yale Canc Ctr, New Haven, CT USA Mem Sloan Kettering Canc Ctr, New York, NY USAGarralda, Elena论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Inst Oncol, Barcelona, Spain Mem Sloan Kettering Canc Ctr, New York, NY USAWulf, Gerburg论文数: 0 引用数: 0 h-index: 0机构: Beth Israel Deaconess Med Ctr, Boston, MA USA Mem Sloan Kettering Canc Ctr, New York, NY USAAlmon, Caroline论文数: 0 引用数: 0 h-index: 0机构: Agios Pharmaceut Inc, Cambridge, MA USA Mem Sloan Kettering Canc Ctr, New York, NY USANabhan, Salah论文数: 0 引用数: 0 h-index: 0机构: Agios Pharmaceut Inc, Cambridge, MA USA Mem Sloan Kettering Canc Ctr, New York, NY USAAguado-Fraile, Elia论文数: 0 引用数: 0 h-index: 0机构: Agios Pharmaceut Inc, Cambridge, MA USA Mem Sloan Kettering Canc Ctr, New York, NY USAHe, Peng论文数: 0 引用数: 0 h-index: 0机构: Servier, Boston, MA USA Mem Sloan Kettering Canc Ctr, New York, NY USARomagnoli, Mathilde论文数: 0 引用数: 0 h-index: 0机构: Servier, Gif Sur Yvette, France Mem Sloan Kettering Canc Ctr, New York, NY USAHossain, Mohammad论文数: 0 引用数: 0 h-index: 0机构: Agios Pharmaceut Inc, Cambridge, MA USA Servier, Boston, MA USA Mem Sloan Kettering Canc Ctr, New York, NY USANarayanaswamy, Rohini论文数: 0 引用数: 0 h-index: 0机构: Servier, Boston, MA USA Mem Sloan Kettering Canc Ctr, New York, NY USASadou-Dubourgnoux, Amel论文数: 0 引用数: 0 h-index: 0机构: Servier, Gif Sur Yvette, France Mem Sloan Kettering Canc Ctr, New York, NY USACooper, Michael论文数: 0 引用数: 0 h-index: 0机构: Agios Pharmaceut Inc, Cambridge, MA USA Servier, Boston, MA USA Mem Sloan Kettering Canc Ctr, New York, NY USAAskoxylakis, Vasileios论文数: 0 引用数: 0 h-index: 0机构: Servier, Boston, MA USA Mem Sloan Kettering Canc Ctr, New York, NY USABurris, Howard A.论文数: 0 引用数: 0 h-index: 0机构: Sarah Cannon Res Inst, Nashville, TN USA Mem Sloan Kettering Canc Ctr, New York, NY USATabernero, Josep论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Inst Oncol, Barcelona, Spain Mem Sloan Kettering Canc Ctr, New York, NY USA
- [50] First-in-man Phase I trial of BYK408740, an oral histone deacetylase inhibitor, in patients with advanced malignanciesEJC SUPPLEMENTS, 2008, 6 (12): : 123 - 124Ang, J. E.论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Drug Dev Unit, Sutton, Surrey, England Royal Marsden Hosp, Drug Dev Unit, Sutton, Surrey, EnglandHauns, B.论文数: 0 引用数: 0 h-index: 0机构: Nycomed GmbH, Exploratory Clin Dev, Constance, Germany Royal Marsden Hosp, Drug Dev Unit, Sutton, Surrey, EnglandMais, A.论文数: 0 引用数: 0 h-index: 0机构: Nycomed GmbH, Exploratory Clin Dev, Constance, Germany Royal Marsden Hosp, Drug Dev Unit, Sutton, Surrey, EnglandParker, A.论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Drug Dev Unit, Sutton, Surrey, England Royal Marsden Hosp, Drug Dev Unit, Sutton, Surrey, EnglandLal, R.论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Drug Dev Unit, Sutton, Surrey, England Royal Marsden Hosp, Drug Dev Unit, Sutton, Surrey, EnglandOlmos, D.论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Drug Dev Unit, Sutton, Surrey, England Royal Marsden Hosp, Drug Dev Unit, Sutton, Surrey, EnglandMollenhauer, M.论文数: 0 引用数: 0 h-index: 0机构: Nycomed GmbH, Exploratory Clin Dev, Constance, Germany Royal Marsden Hosp, Drug Dev Unit, Sutton, Surrey, EnglandWalz, A.论文数: 0 引用数: 0 h-index: 0机构: Nycomed GmbH, Exploratory Clin Dev, Constance, Germany Royal Marsden Hosp, Drug Dev Unit, Sutton, Surrey, Englandde Bono, J. S.论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, Drug Dev Unit, Sutton, Surrey, England Royal Marsden Hosp, Drug Dev Unit, Sutton, Surrey, England